According to the Zhitong Finance App, Taimei Medical Technology (02576.HK) announced interim results for the six months ended June 30, 2026. The group's revenue was RMB 264 million, up 8% year on year; net loss was RMB 48.161 million, up 64.3% year on year; and loss per share was 0.08 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.